FRI0212 USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPY

Galina Tarasova, Т. В. Попкова, Е. А. Асеева et al.|Annals of the Rheumatic Diseases|2019

Cited by 7